Clinical Trial Update: A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula [Phase 2]

View source ↗

Summary

Phase II trial evaluating lanreotide to prevent postoperative pancreatic fistula after pancreatic surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Fistula
• Pancreatic Leak
• Pancreaticoduodenal Fistula
• Postoperative Pancreatic Complications

Drugs mentioned

• Lanreotide (lanreotide)

Snippet

Sponsor: University of Washington | Conditions: Pancreatic Leak, Pancreatic Fistula | Phase 2 | Status: COMPLETED | Results posted: 2022-06-16